Metastatic Castration Sensitive Prostate Cancer
Also known as: Metastatic Castration Sensitive Prostate Cancer (mCSPC) / Metastatic Castration-sensitive Prostate Cancer / Metastatic Castrate Sensitive Prostate Cancer / Metastatic Castrate-sensitive Prostate Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB05812 | Abiraterone | An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. |
DB11901 | Apalutamide | An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. |
DB08899 | Enzalutamide | A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. |